Vicore Pharma's drug candidate, C21 formulation patented
Vicore Pharma’s drug candidate, C21 formulation, currently in a phase 2a trial aimed at people with idiopathic pulmonary fibrosis (IPF), has been patented.
Source: outsourcing-pharma.com
New Delayed Release Composition News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from New Delayed Release Composition. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In New Delayed Release Composition Today - Breaking & Trending Today